| A |
Adherence to Antipsychotic Medications for Individuals with Schizophrenia |
Effectiveness of Care |
|
SAA |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Appropriate Testing for Pharyngitis |
Effectiveness of Care |
|
CWP |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
NR |
✓ |
HEDIS 2026 |
● |
| A |
Appropriate Treatment for Upper Respiratory Infection |
Effectiveness of Care |
|
URI |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
A |
Asthma Medication Ratio |
Effectiveness of Care |
5 |
AMR |
4 |
4 |
4 |
4 |
4 |
4 |
4 |
4 |
HEDIS 2025 |
|
| A |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis |
Effectiveness of Care |
|
AAB |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
NR |
✓ |
HEDIS 2026 |
● |
| A/H |
Blood Pressure Control for Patients With Diabetes |
Effectiveness of Care |
|
BPD |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Cardiac Rehabilitation |
Effectiveness of Care |
|
CRE |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Cardiovascular Monitoring for People With Cardiovascular Disease and Schizophrenia |
Effectiveness of Care |
|
SMC |
NR |
NR |
NR |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Chlamydia Screening |
Effectiveness of Care |
2 |
CHL |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A/H |
Controlling High Blood Pressure |
Effectiveness of Care |
5 |
CBP |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
COVID-19 Immunization Status |
Effectiveness of Care |
|
CVS |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
NYSQARR 2026 |
● |
| A |
Diabetes Monitoring for People With Diabetes and Schizophrenia |
Effectiveness of Care |
|
SMD |
NR |
NR |
NR |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Diabetes Screening for People With Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications |
Effectiveness of Care |
|
SSD |
NR |
NR |
NR |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Developmental Screening in the First Three Years of Life |
Effectiveness of Care |
|
DEV-N |
✓ |
✓ |
NR |
NR |
NR |
✓ |
NR |
NR |
OHSU (NYS QARR 2026) |
● |
| A |
Eye Exam for Patients With Diabetes (Removed the Hybrid Data Collection Method) |
Effectiveness of Care |
5 |
EED |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Follow-Up After Emergency Department Visit for Mental Illness |
Effectiveness of Care |
3, 5 |
FUM |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Follow-Up After Emergency Department Visit for Substance Use |
Effectiveness of Care |
3, 5 |
FUA |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Follow-Up After High-Intensity Care for Substance Use Disorder |
Effectiveness of Care |
3 |
FUI |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Follow-Up After Hospitalization for Mental Illness |
Effectiveness of Care |
1, 3, 5 |
FUH |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A/H |
Glycemic Status Assessment for Patients With Diabetes |
Effectiveness of Care |
1, 5 |
GSD |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Kidney Health Evaluation for Patients With Diabetes |
Effectiveness of Care |
5 |
KED |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
A/H |
Lead Screening in Children |
Effectiveness of Care |
6 |
LSC |
4 |
4 |
NR |
NR |
NR |
4 |
4 |
NR |
HEDIS 2025 |
|
S |
Medical Assistance With Smoking and Tobacco Use Cessation |
Effectiveness of Care |
4 |
MSC |
4 |
4 |
4 |
4 |
4 |
4 |
4 |
4 |
CAHPS 5.1H |
|
| A |
Oral Evaluation, Dental Services |
Effectiveness of Care |
|
OED |
NR |
NR |
NR |
✓ |
✓ |
✓ |
✓ |
NR |
HEDIS 2026 |
● |
| A |
Persistence of Beta-Blocker Treatment After a Heart Attack |
Effectiveness of Care |
|
PBH |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Pharmacotherapy for Opioid Use Disorder |
Effectiveness of Care |
5 |
POD |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Pharmacotherapy Management of COPD Exacerbation |
Effectiveness of Care |
|
PCE |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Proportion of Days Covered |
Effectiveness of Care |
|
PDC |
NR |
NR |
NR |
✓ |
✓ |
NR |
NR |
NR |
QRS/PQA |
● |
| A |
Risk of Continued Opioid Use |
Effectiveness of Care |
|
COU |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Sexually Transmitted Infection Screening in High-Risk Population |
Effectiveness of Care |
7 |
STI |
NR |
NR |
NR |
NR |
NR |
NR |
✓ |
NR |
NYSQARR 2026 |
|
A |
Statin Therapy for Patients With Cardiovascular Disease |
Effectiveness of Care |
|
SPC |
4 |
4 |
4 |
NR |
NR |
4 |
4 |
4 |
HEDIS 2025 |
|
A |
Statin Therapy for Patients With Diabetes |
Effectiveness of Care |
|
SPD |
4 |
4 |
4 |
NR |
NR |
4 |
4 |
4 |
HEDIS 2025 |
|
| A |
Topical Fluoride for Children |
Effectiveness of Care |
|
TFC |
NR |
NR |
NR |
NR |
NR |
✓ |
✓ |
NR |
HEDIS 2026 |
● |
| A |
Use of Imaging Studies for Low Back Pain |
Effectiveness of Care |
|
LBP |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Use of Opioids at High Dosage |
Effectiveness of Care |
|
HDO |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Use of Opioids from Multiple Providers |
Effectiveness of Care |
|
UOP |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Viral Load Suppression |
Effectiveness of Care |
7 |
VLS |
NR |
NR |
NR |
NR |
NR |
✓ |
✓ |
✓ |
NYSQARR 2026 |
|
| A/H |
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents |
Effectiveness of Care |
|
WCC |
✓ |
✓ |
NR |
✓ |
✓ |
✓ |
✓ |
NR |
HEDIS 2026 |
● |
| Access / Availability of Care |
| A |
Adults' Access to Preventive/Ambulatory Health Services |
Access/Availability of Care |
|
AAP |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Antibiotic Utilization for Respiratory Conditions |
Access / Availability of Care |
|
AXR |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Initiation and Engagement of Substance Use Disorder Treatment |
Access / Availability of Care |
5 |
IET |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A/H |
Prenatal and Postpartum Care |
Access / Availability of Care |
5 |
PPC |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics |
Access / Availability of Care |
|
APP |
✓ |
✓ |
NR |
NR |
NR |
✓ |
✓ |
NR |
HEDIS 2026 |
● |
| Health Plan Descriptive Information |
| |
Enrollment by Product Line |
Access / Availability of Care |
|
ENP |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
|
| Utilization and Risk Adjusted Utilization |
| A |
Acute Hospital Utilization |
Utilization & Risk Adjusted Utilization |
|
AHU |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
|
| A |
Child and Adolescent Well-Care Visits |
Utilization & Risk Adjusted Utilization |
1, 5 |
WCV |
✓ |
✓ |
NR |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Diagnosed Mental Health Disorders |
Utilization & Risk Adjusted Utilization |
|
DMH |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Diagnosed Substance Use Disorder |
Utilization & Risk Adjusted Utilization |
|
DSU |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| A |
Emergency Department Utilization |
Utilization & Risk Adjusted Utilization |
|
EDU |
✓ |
✓ |
✓ |
NR |
NR |
NR |
NR |
NR |
HEDIS 2026 |
|
| A |
Plan All-Cause Readmission |
Utilization & Risk Adjusted Utilization |
|
PCR |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
|
| A |
Well-Child Visits in the First 30 Months of Life |
Utilization & Risk Adjusted Utilization |
1, 5 |
W30 |
✓ |
✓ |
NR |
✓ |
✓ |
✓ |
✓ |
NR |
HEDIS 2026 |
● |
| Measures Collected Using Electronic Clinical Data Systems |
| E |
Adult Immunization Status |
ECDS |
5 |
AIS-E |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Blood Pressure Control for Patients With Diabetes |
ECDS |
|
BPD-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Blood Pressure Control for Patients With Hypertension |
ECDS |
5 |
BPC-E |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Breast Cancer Screening |
ECDS |
5 |
BCS-E |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Cervical Cancer Screening |
ECDS |
5 |
CCS-E |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Childhood Immunization Status |
ECDS |
1, 5 |
CIS-E |
✓ |
✓ |
NR |
✓ |
✓ |
✓ |
✓ |
NR |
HEDIS 2026 |
● |
| E |
Colorectal Cancer Screening |
ECDS |
5 |
COL-E |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Depression Remission or Response for Adolescents and Adults |
ECDS |
|
DRR-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Depression Screening and Follow-Up for Adolescents and Adults |
ECDS |
|
DSF-E |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Documented Assessment After Mammogram |
ECDS |
|
DBM-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Follow-Up After Abnormal Mammogram Assessment |
ECDS |
|
FMA-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Follow-Up After Acute and Urgent Care Visits for Asthma |
ECDS |
|
AAF-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Follow-Up Care for Children Prescribed ADHD Medication |
ECDS |
|
ADD-E |
✓ |
✓ |
NR |
NR |
NR |
✓ |
✓ |
NR |
HEDIS 2026 |
● |
| E |
Immunizations for Adolescents |
ECDS |
1, 5 |
IMA-E |
✓ |
✓ |
NR |
✓ |
✓ |
✓ |
✓ |
NR |
HEDIS 2026 |
● |
| E |
Lead Screening in Children |
ECDS |
6 |
LSC-E |
✓ |
✓ |
NR |
NR |
NR |
✓ |
✓ |
NR |
HEDIS 2026 |
● |
| E |
Metabolic Monitoring for Children and Adolescents on Antipsychotics |
ECDS |
|
APM-E |
✓ |
✓ |
NR |
NR |
NR |
✓ |
✓ |
NR |
HEDIS 2026 |
● |
| E |
Prenatal Depression Screening and Follow-Up |
ECDS |
5 |
PND-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Postpartum Depression Screening and Follow-Up |
ECDS |
5 |
PDS-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Prenatal Immunization Status |
ECDS |
5 |
PRS-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Social Need Screening and Intervention |
ECDS |
|
SNS-E |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Statin Therapy for Patients With Cardiovascular Disease |
ECDS |
|
SPC-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Statin Therapy for Patients With Diabetes |
ECDS |
|
SPD-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Tobacco Use Screening and Cessation Intervention (TSC-E) |
ECDS |
|
TSC-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Unhealthy Alcohol Use Screening and Follow-Up |
ECDS |
|
ASF-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| E |
Utilization of the PHQ-9 to Monitor
Depression Symptoms for Adolescents and Adults |
ECDS |
|
DMS-E |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
HEDIS 2026 |
● |
| Experience of Care |
| S |
CAHPS Health Plan Survey 5.1H Adult Version |
Experience of Care |
✓ |
CPA |
✓ |
✓ |
✓ |
NR |
NR |
NR |
NR |
NR |
HEDIS 2026 |
|
| S |
CAHPS Health Plan Survey 5.1H Child Version |
Experience of Care |
✓ |
CPC |
NR |
NR |
NR |
NR |
NR |
NR |
NR |
NR |
HEDIS 2026 |
|
| S |
QHP Enrollee Experience Survey |
Experience of Care |
|
|
NR |
NR |
NR |
✓ |
✓ |
NR |
NR |
NR |
QRS |
De-identified member file |
| NYS QARR 2026-Specific Prenatal Care Measures |
| A |
Risk-Adjusted Low Birth Weight |
NYS QARR 2025-Specific Prenatal Care Measures |
7 |
|
These prenatal care measures will be calculated by the Office of Health Services and Analytics (OHSQA) using the birth data submitted by plans and the Department's Vital Statistics Birth File. |
NYSQARR 2026 |
|
| A |
Prenatal Care in the First Trimester |
NYS QARR 2025-Specific Prenatal Care Measures |
7 |
|
NYSQARR 2026 |
|
| A |
Risk-Adjusted Primary C-Section |
NYS QARR 2025-Specific Prenatal Care Measures |
7 |
|
NYSQARR 2026 |
|
| A |
Vaginal Birth After C-section |
NYS QARR 2025-Specific Prenatal Care Measures |
7 |
|
NYSQARR 2026 |
|
| NYS QARR 2026-Specific Behavioral Health Measures |
| A |
Continued Engagement in Substance Use Disorder Treatment |
NYS QARR 2025-Specific Behavioral Health Measures |
|
CET |
✓ |
✓ |
✓ |
NR |
NR |
✓ |
✓ |
✓ |
NYSQARR 2026 |
● |
| A |
Initiation of Pharmacotherapy upon New Episode of Opioid Dependence |
NYS QARR 2025-Specific Behavioral Health Measures |
|
POD-N |
NR |
NR |
NR |
NR |
NR |
✓ |
✓ |
✓ |
NYSQARR 2026 |
● |
| A |
Use of Pharmacotherapy for Alcohol Use or Dependence |
NYS QARR 2025-Specific Behavioral Health Measures |
|
POA |
NR |
NR |
NR |
NR |
NR |
✓ |
✓ |
✓ |
NYSQARR 2026 |
● |
| A |
Potentially Preventable Mental Health Related Readmission Rate 30 Days |
NYS QARR 2025-Specific Behavioral Health Measures |
7 |
PPR-MH |
This measure will be calculated by New York State using 3M Software and health plan submitted encounters. |
NYSQARR 2026 |
|
| A |
Utilization of Recovery-Oriented Services for Mental Health |
NYS QARR 2025-Specific Behavioral Health Measures |
7 |
URO |
This measure will be calculated and reported by New York State. No plan reporting is required. |
NYSQARR 2026 |
|